| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/26/2007 | US20070172920 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 07/26/2007 | US20070172918 Non aggregating fluorescent proteins and methods for using the same |
| 07/26/2007 | US20070172917 Cytokine receptor zalpha11 |
| 07/26/2007 | US20070172909 Non-ribosomal peptide synthetases and associated biosynthetic genes |
| 07/26/2007 | US20070172893 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 07/26/2007 | US20070172892 Novel polypeptide esdn, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 07/26/2007 | US20070172883 Comparative fluorescence hybridization to nucleic acid arrays |
| 07/26/2007 | US20070172881 Expression vector comprising fungal gene sequences for use as tool in identifying antifungal polypeptides for use in treatment and prevention of fungal infection |
| 07/26/2007 | US20070172880 Transient Receptor Potential Channels is an emerging class of Ca2+-permeable cation channel superfamily; for diagnosis, treatment, and/or prevention of various diseases |
| 07/26/2007 | US20070172879 Thermophilic DNA polymerases from thermoactinomyces vulgaris |
| 07/26/2007 | US20070172875 Compositions and Methods for Nucleic Acid Extraction from Biological Samples |
| 07/26/2007 | US20070172874 Compositions and Methods for Nucleic Acid Extraction from Biological Samples |
| 07/26/2007 | US20070172868 Compositions for sequence determination using tagged polymerizing agents and tagged monomers |
| 07/26/2007 | US20070172867 Methods for sequence determination |
| 07/26/2007 | US20070172865 Sequence determination in confined regions |
| 07/26/2007 | US20070172864 Composition for sequence determination |
| 07/26/2007 | US20070172863 Compositions and methods for sequence determination |
| 07/26/2007 | US20070172862 Data stream determination |
| 07/26/2007 | US20070172861 Mutant polymerases |
| 07/26/2007 | US20070172858 Methods for sequence determination |
| 07/26/2007 | US20070172856 Materials and methods for treating chronic fibrotic diseases |
| 07/26/2007 | US20070172848 Novel calpastatin (cast) alleles |
| 07/26/2007 | US20070172833 Gene expression profile retrieving apparatus, gene expression profile retrieving method, and program |
| 07/26/2007 | US20070172827 Multiplex detection probes |
| 07/26/2007 | US20070172826 Electrochemically active ligand for sequence-specific detection of double-stranded nucleic acid molecule |
| 07/26/2007 | US20070172825 Methods and kits for identifying functions and binding substances of gene products |
| 07/26/2007 | US20070172544 Method of quickly measuring factor causing early flocculation of yeast |
| 07/26/2007 | US20070172504 In vivo cell surface engineering |
| 07/26/2007 | US20070172500 Anthrax antitoxins |
| 07/26/2007 | US20070172494 Cold-adapted equine influenza viruses |
| 07/26/2007 | US20070172493 12832, a novel human kinase-like molecule and uses thereof |
| 07/26/2007 | US20070172488 cell proliferation-inhibiting activity by ADCC (antibody-dependent cell-mediated cytotoxicity) activity and CDC (complement-dependent cytotoxicity); hepatic cancer |
| 07/26/2007 | US20070172486 used to treat tumor (osteosarcoma or Ewing's sarcoma); restenosis |
| 07/26/2007 | US20070172480 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 07/26/2007 | US20070172470 Phosphatase regulation of nucleic acid transcription |
| 07/26/2007 | US20070172467 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin |
| 07/26/2007 | US20070172462 siRNA-mediated gene silencing of synuclein |
| 07/26/2007 | US20070172461 Polyepitope vaccines |
| 07/26/2007 | US20070172460 Random peptide library displayed on aav vectors |
| 07/26/2007 | US20070172459 modified interferons for use in the treatment and prevention of viral infections, cell proliferative and autoimmune disorders |
| 07/26/2007 | US20070172458 IL-6/IL-6R fusion protein |
| 07/26/2007 | US20070172455 Chimeric Interleukin-6 Soluble Receptor/Ligand Protein, Analogs Thereof and Uses Thereof |
| 07/26/2007 | US20070172454 Use of il-6/il-6 chimera in huntington's disease |
| 07/26/2007 | CA2675534A1 Mutant jak3 kinase in human leukemia |
| 07/26/2007 | CA2644675A1 Nucleotide sequences and corresponding polypeptides conferring improved nitrogen use efficiency characteristics in plants |
| 07/26/2007 | CA2638904A1 Methods for profiling transcriptosomes |
| 07/26/2007 | CA2637931A1 Chemically modified polycation polymer for sirna delivery |
| 07/26/2007 | CA2637835A1 Marker and method for cancer diagnosis |
| 07/26/2007 | CA2637730A1 Soluble fragments of the sars-cov spike glycoprotein |
| 07/26/2007 | CA2637719A1 C-terminal exon 5.4 of runx1/aml1 |
| 07/26/2007 | CA2637254A1 Compositions and methods for humanization and optimization of n-glycans in plants |
| 07/26/2007 | CA2637252A1 Plants and plant cells having inhibited expression of .alpha.1,3-fucosyltransferase and .beta.1,2-xylosyltransferase |
| 07/26/2007 | CA2637031A1 Methods and compositions for ethanol producing cyanobacteria |
| 07/26/2007 | CA2636771A1 Epsps mutants |
| 07/26/2007 | CA2636600A1 Novel protein expression system |
| 07/26/2007 | CA2636111A1 Codon optimized il- 15 and il- 15r-alpha genes for expression in mammalian cells |
| 07/26/2007 | CA2635723A1 Therapeutic uses of inhibitors of rtp801 |
| 07/26/2007 | CA2633844A1 Novel fsh glycosylation variant d3n |
| 07/26/2007 | CA2632943A1 Novel synthetic agonists of toll-like receptors containing cg dinucleotide modifications |
| 07/26/2007 | CA2622671A1 Methods for controlling pests using rnai |
| 07/25/2007 | EP1811299A1 Bioassay equipment and bioassay method |
| 07/25/2007 | EP1811042A2 cDNA synthesis improvements |
| 07/25/2007 | EP1811036A2 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 07/25/2007 | EP1811035A1 Aspartic proteinase 2 (ASP2) |
| 07/25/2007 | EP1811034A2 Compounds and method for inhibiting axillary malodour |
| 07/25/2007 | EP1811033A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 07/25/2007 | EP1811032A1 C-terminal exon 5.4 of RUNX1/AML1 |
| 07/25/2007 | EP1811031A1 Method for selecting a peptide or polypeptide which binds to a target molecule |
| 07/25/2007 | EP1811030A1 Method of stabilizing, and bluing, of anthocyanin pigment using gene coding for transferase of aromatic acyl to 3 -position of anthocyanin |
| 07/25/2007 | EP1811029A1 Method of isolating p450 gene |
| 07/25/2007 | EP1811028A1 Improved hydroxynitrile lyase |
| 07/25/2007 | EP1811027A1 Polynucleotide for production of recombinant protein by silkworm |
| 07/25/2007 | EP1811026A1 Method of immunizing animal, composition for immunization, method of producing antibody, method of producing hybridoma and method of producing monoclonal antibody |
| 07/25/2007 | EP1811025A1 Mutated amyloid protein |
| 07/25/2007 | EP1811024A1 Oligo double-stranded rna and medicinal composition |
| 07/25/2007 | EP1811023A1 Gene expressed specifically in es cells and utilization of the same |
| 07/25/2007 | EP1811022A1 Arylacylamidase gene and method of using the same |
| 07/25/2007 | EP1811021A1 Novel carbonyl reductase, gene therefor and use thereof |
| 07/25/2007 | EP1811020A1 Escherichia coli phytase |
| 07/25/2007 | EP1810980A1 Interleukin-6 inhibitors |
| 07/25/2007 | EP1810979A1 STABILIZED HUMAN IgG4 ANTIBODIES |
| 07/25/2007 | EP1810978A2 Group B streptococcus polypeptides nucleic acids and therapeutic composition and vaccines thereof |
| 07/25/2007 | EP1810685A1 Use of dimer-specific nuclear localisation signal peptides (dsNLS) derived from the STAT DNA binding domain |
| 07/25/2007 | EP1809773A2 Yeast-based therapeutic for chronic hepatitis c infection |
| 07/25/2007 | EP1809761A2 Compositions and methods for modulating dhr96 |
| 07/25/2007 | EP1809758A2 In vivo site-specific incorporation of n-acetyl-galactosamine amino acids in eubacteria |
| 07/25/2007 | EP1809756A2 Docosahexaenoic acid producing strains of yarrowia lipolytica |
| 07/25/2007 | EP1809754A2 Producing hydrogen by heterologous expression of a type ii nad (p) h dehydrogenase in chlamydomonas |
| 07/25/2007 | EP1809753A1 Adenoviral amplicon and producer cells for the production of replication-defective adenoviral vectors, methods of preparation and use thereof |
| 07/25/2007 | EP1809752A1 Enzymes involved in triterpene synthesis |
| 07/25/2007 | EP1809751A2 Collagen producing plants and methods of generating and using same |
| 07/25/2007 | EP1809750A2 Selection of host cells expressing protein at high levels |
| 07/25/2007 | EP1809749A2 Methods for heterologous expression of secondary metabolites |
| 07/25/2007 | EP1809748A2 Micrornas |
| 07/25/2007 | EP1809747A2 Polypeptides having phytase activity and polynucleotides encoding same |
| 07/25/2007 | EP1809746A1 Polynucleotides for the detection of listeria species |
| 07/25/2007 | EP1809745A2 COMPOSITIONS AND METHODS FOR SHORT INTERFERING NUCLEIC ACID INHIBITION OF NAv1.8 |
| 07/25/2007 | EP1809744A1 Compositions and methods for purifying nucleic acids from stabilization reagents |
| 07/25/2007 | EP1809743A1 Structural nucleid acid guided chemical synthesis |
| 07/25/2007 | EP1809741A1 Endo-n-acetyl-beta-d-glucosaminidase enzymes of filamentous fungi |